Disclosed is a method of down-regulating the expression of a gene in an animal, wherein a pharmacological formulation comprising a chimeric oligonucleotide complementary to the gene is orally administered to an animal. The oligonucleotide administered has at least one phosphorothioate internucleotide linkage and at least one alkylphosphonate, phosphorodithioate, alkylphosphonothioate, phosphoramidate, phosphoramidite, phosphate ester, carbamate, carbonate, phosphate triester, acetamidate, or carboxymethyl ester internucleotide linkage.

 
Web www.patentalert.com

< Human mesenchymal progenitor cell

< Benzazepine derivatives, process for the preparation of the same and uses thereof

> Hollow fiber contactor systems for removal of lipids from fluids

> Highly infectious rubella virus DNA constructs and methods of production

~ 00204